Intracranial Thrombosis clinical trials
The registry lists 46 studies for Intracranial Thrombosis across more than 10 countries. 15 are recruiting or about to start. 29 of them are mainly about Intracranial Thrombosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-26.
Get an email when these change. Save the Intracranial Thrombosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Xuanwu Hospital, Beijing (4) · Kafrelsheikh University (3) · Capital Medical University (3) · Assiut University (2) · Academic and Community Cancer Research United (2) · Medical University of South Carolina (1) · Damascus University (1) · University Hospital, Rouen (1)
What is being tested here
Drugs under test in Intracranial Thrombosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Rivaroxaban | 2 | 3 | 6 |
| Apixaban | 1 | 4 | 4 |
| Dabigatran | 1 | 3 | 3 |
| Tenecteplase | 1 | 2 | 2 |
| Tocilizumab | 1 | 0 | 1 |
| Tissue Plasminogen Activator | 0 | 2 | 2 |
| Dalteparin | 0 | 1 | 1 |
| Warfarin | 0 | 0 | 1 |
Drug classes tested here Factor Xa inhibitors 2 open · Thrombolytics 2 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4, phase 3 first
- Dec 2026Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · Xuanwu Hospital, Beijing
- Dec 2026REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study · Johns Hopkins University
- Dec 2026The Norwegian Cerebral Venous Thrombosis Study · University Hospital, Akershus
- Oct 2027TOF-MRV Versus Post-Contrast 3D T1 MRI in Dural Venous Sinus Thrombosis · Assiut University
Who these studies take
Of the 14 Intracranial Thrombosis studies recruiting now, 7 (50%) set no upper age limit and 2 (14%) stop at 75 or younger. 2 (14%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (7%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (14%) | 2 (14%) |
| 18 | 14 (100%) | 14 (100%) |
| 30 | 14 (100%) | 14 (100%) |
| 40 | 14 (100%) | 14 (100%) |
| 50 | 14 (100%) | 14 (100%) |
| 65 | 14 (100%) | 14 (100%) |
| 75 | 14 (100%) | 14 (100%) |
| 85 | 9 (64%) | 9 (64%) |
Across all 46 studies, recruiting or not: 24% stop at 75 or younger and 15% at 65; 24% take children; 0% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 14, 2026.
Newly registered2
- TOF-MRV Versus Post-Contrast 3D T1 MRI in Dural Venous Sinus ThrombosisOct 22, 2026NCT07888062
- Danang Cerebral Venous Thrombosis RegistryOct 22, 2026NCT07890675
Studies
Recruiting first, then most recently updated. Showing 46 of 46. search them.
- Danang Cerebral Venous Thrombosis RegistryRecruitingNCT078906751 country
- TOF-MRV Versus Post-Contrast 3D T1 MRI in Dural Venous Sinus ThrombosisNot yet recruitingNCT07888062
- Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in VietnamRecruitingNCT070836091 country
- The Erlanger Stroke Registry (ESPro) is the Only Ongoing Prospective Population-based Stroke Registry in Germany, Started in 1994. ESPro Includes All Hospitalized and Non-hospitalized Patients With Stroke in the Community of Erlangen (120.000 Inhabitants), With a Long-life Follow-up.RecruitingNCT077713351 country
- Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related DiseaseRecruitingNCT078135591 country
- Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous ThrombosisRecruitingNCT07801638Not applicable1 country
- Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion StrokeRecruitingNCT06658197Phase 31 country
- Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous ThrombosisRecruitingNCT07352358Phase 41 country
- Stroke Thrombectomy and Aneurysm RegistryRecruitingNCT049947569 countries
- Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese PatientsRecruitingNCT069477071 country
- The Norwegian Cerebral Venous Thrombosis StudyRecruitingNCT050211981 country
- Rivaroxaban Versus Apixaban in Cerebral Venous ThrombosisRecruitingNCT06531122Phase 31 country
- Direct Oral Anticoagulants for the Treatment of Cerebral Venous ThrombosisRecruitingNCT046607471 country
- Dabigatran Versus Rivaroxaban in Cerebral Venous ThrombosisRecruitingNCT06551402Phase 31 country
- Thrombus Imaging and Treatment Analytics in NeurologyRecruitingNCT056632811 country
- Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUSActive, not recruitingNCT033293651 country
- adaptatiVe Endovascular Strategy to the CloT MRI in Large Intracranial Vessel OcclusionCompletedNCT04139486Not applicable1 country
- Florida Cerebrovascular Disease Biorepository and Genomics CenterActive, not recruitingNCT054919801 country
- REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage StudyActive, not recruitingNCT056119181 country
- Thrombin Generation and Thrombus Degradation in Cerebral Venous Thrombosis : Clinical and Radiological CorrelationsCompletedNCT02013635Not applicable1 country
- Intracranial Hypertension and Optic Nerve Sheath DiameterCompletedNCT01796015Not applicable1 country
- Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.CompletedNCT059908941 country
- DOAC in Unusual Site Venous ThrombosisCompletedNCT0377850210 countries
- Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation TherapyCompletedNCT03080883Phase 31 country
- Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and OutcomeActive, not recruitingNCT0193472513 countries
- Philippine Neurological Association One Database - StrokeCompletedNCT049720581 country
- Dabigatran Versus Apixaban in Cerebral Venous ThrombosisStatus unknownNCT06551415Phase 31 country
- Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)CompletedNCT054482481 country
- Clinical Deterioration in Cerebral Venous Thrombosis: A Predictive StudyCompletedNCT062665851 country
- Alteplase Compared to Tenecteplase in Patients With Acute Ischemic StrokeCompletedNCT03889249Phase 31 country
- Rivaroxaban vs. Warfarin in CVT TreatmentCompletedNCT04569279Phase 31 country
- Study of Rivaroxaban for CeREbral Venous ThrombosisCompletedNCT03178864Phase 21 country
- Venous Sinus Thrombosis : Clinical Picture and OutcomeStatus unknownNCT05211102
- Good Prognosis Factors After Decompressive Craniectomy : a Ten-year Retrospective StudyCompletedNCT046829511 country
- Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic EventsStatus unknownNCT045193981 country
- Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous ThromboembolismCompletedNCT02585713Phase 31 country
- Volumetric Integral Phase-shift Spectroscopy for Noninvasive Detection of Hemispheric Bioimpedance Asymmetry in Acute Brain PathologyCompletedNCT031483401 country
- Efficacy Comparison of Warfarin Versus Rivaroxaban CVTStatus unknownNCT03747081Phase 1/21 country
- The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)CompletedNCT009248592 countries
- Cyanotic Heart Disease and ThrombosisCompletedNCT02716402Not applicable1 country
- The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous ThrombosisStatus unknownNCT03217448Phase 31 country
- Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous ThrombosisStatus unknownNCT03191305Not applicable
- Thrombolysis or Anticoagulation for Cerebral Venous ThrombosisTerminatedNCT01204333Phase 2/36 countries
- Evaluation of Cerebral Oxygenation and Hemodynamics in Patients With Cerebral Venous ThrombosisCompletedNCT030339661 country
- Modern Ultrasound Techniques in the Evaluation of Cerebral Venous Sinuses in NeonatesCompletedNCT00555932Not applicable1 country
- Impact of Cranioplasty On Cerebral PerfusionCompletedNCT011136451 country